Aptose Receives $10M From Hanmi; Negotiating Future Collaboration
30 Aug 2024 //
GLOBENEWSWIRE
Aptose Reports Results for the Second Quarter 2024
08 Aug 2024 //
GLOBENEWSWIRE
Aptose Presents Tuspetinib Findings At EHA 2024
14 Jun 2024 //
GLOBENEWSWIRE
Aptose Tuspetinib Data Featured in Oral Presentation
09 Dec 2023 //
GLOBENEWSWIRE
Aptose Tuspetinib Clinical Data Selected for Presentation at the 2023 ASH
02 Nov 2023 //
GLOBENEWSWIRE
Aptose Presents Highlights from Webcast Featuring Data on AML Drug Tuspetinib
30 Oct 2023 //
GLOBENEWSWIRE
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib
23 Oct 2023 //
GLOBENEWSWIRE